Global Erectile Dysfunction Market By Overview
Erectile dysfunction is also recognized as impotence. It is the state of sexual dysfunction where males cannot keep the erection during sexual intercourse. It’s primarily caused by prolonged diseases like neurological issues, hormonal insufficiency, cardiovascular diseases, diabetes, and drug side effects. Moreover, it could develop owing to the shortage of penile blood supply, obesity, excessive alcohol intake, smoking, and psychological problems. Erectile dysfunction may be addressed by an extensive range of involvements that comprises penile implants, pharmacotherapy, erection devices, change in lifestyles like smoking cessation, exercise, and reduction in alcohol intake, and drug injections into the penis. Increasing awareness about erectile sexual diseases or dysfunction among people is likely to fuel the global market growth over the forecast period. Pin-point study of erectile dysfunction market emphases on numerous aspects of the market such as market drivers, market restraints, market trends, as well as opportunities. Competitive scenery focuses on important leaders operating in the erectile dysfunction market and their key growth strategies. The Erectile Dysfunction Market accounted for US$ 5.54 billion in 2020 and is estimated to be US$ 10.14 billion by 2030 and is anticipated to register a CAGR of 6.2%.
Global Erectile Dysfunction Market By Dynamics
Rising prevalence of chronic diseases
The erectile dysfunction market is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, neurogenic disorders, and psychological disorders. Furthermore, increasing geriatric population, awareness and patient education are key factors fueling the global market growth. Despite growing demand for erectile dysfunction drugs, the market is expected to experience a decline in the coming years owed to the patent cessation of major brands. On the contrary, it could offer the significant opportunity for generic industrialists to enter into the emerging market. However, there is a high prevalence of sexually transmitted diseases (STDs) in the erectile dysfunction medication users, and it may hamper the global market growth. Though, generic drugs can create a lucrative opportunity in this market. Besides, innovative drug delivery methods can also bolster the market growth.
Global Erectile Dysfunction Market By Segmentation
The erectile dysfunction market has been segmented on the basis of therapy type, and region.
On the basis of therapy type, the erectile dysfunction market is fragmented into drug therapy and device therapy. On the basis of region, the target market has been categorized into North America, Asia Pacific, Europe, Latin America, Middle East, and Africa.
Regional Insights:
For detailed understanding of market dynamics, the erectile dysfunction market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. In 2018, North America region dominates the global empty capsules market and is expected to continue its dominance over the forecast period owing to well-developed pharmaceuticals sector in the countries of the region. Asia Pacific market is expected to witness fastest growth in terms of revenue over the forecast period. This is owing to the growing number of pharmaceutical contract research establishments in this region, and major key players shifting their interest towards Asia Pacific to expand their customer base.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Therapy Type- Drug Therapy and Device Therapy |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Erectile Dysfunction Market, By Therapy Type:
- Drug Therapy
- Device Therapy
Erectile Dysfunction Market, By Region:
- North America
- North America Erectile Dysfunction Market, By Therapy
- North America Erectile Dysfunction Market, By Country
- U.S.
- Canada
- Europe
- Europe Erectile Dysfunction Market, By Therapy Type
- Europe Erectile Dysfunction Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Switzerland
- Sweden
- Rest of Europe
- Asia-Pacific
- Asia-Pacific Erectile Dysfunction Market, By Therapy Type
- Asia-Pacific Erectile Dysfunction Market, By Country
- China
- India
- Australia & New Zealand
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Erectile Dysfunction Market, By Therapy Type
- Latin America Erectile Dysfunction Market, By Country
- Brazil
- Mexico
- Argentina and Chile
- Rest of Latin America
- Middle East
- Middle East Erectile Dysfunction Market, By Therapy Type
- Middle East Erectile Dysfunction Market, By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- Africa Erectile Dysfunction Market, By Therapy Type
- Africa Erectile Dysfunction Market, By Country
- North Africa
- Central Africa
- South Africa
Global Erectile Dysfunction Market By Key Players
Key players operating in the erectile dysfunction market includes Teva Pharmaceutical Industries Limited, Bonro Medical, Endo International Plc., Eli Lilly and Company, Futura Medical, Augusta Medical Systems LLC, Pfizer,Cristalia Produtos Quimicos Farmaceuticos Ltda., Premedon,SK Chemicals, Post-T-Vac Medical, Bayer AG, VIVUS Inc., Boston Scientific Corp.,Zephyr Surgical Implants (ZSI), Apricus Biosciences Inc., and Coloplast A/S.
Global Erectile Dysfunction Market By Company Profile
- Apricus Biosciences Inc.
- Business Strategies Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Company Overview
- Endo International Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Futura Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Premedon
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Teva Pharmaceutical Industries Limited (Teva)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Zephyr Surgical Implants (ZSI)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Augusta Medical Systems LLC (Augusta Medical)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Post-T-Vac Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Bonro Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Cristalia Produtos Quimicos Farmaceuticos Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- SK Chemicals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Bayer AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- VIVUS Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Pfizer
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Boston Scientific Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Coloplast A/S
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
Global Erectile Dysfunction Market By Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Drivers- Restraints Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Market Segmentation, By Therapy Type, 2018 – 2028
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Drug Therapy
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Device Therapy
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Global Market, By Region, 2018 – 2028
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- U.S.
- Canada
- Latin America
- Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- Brazil
- Mexico
- Argentina and Chile
- Rest of Latin America
- Europe
- Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- Germany
- UK
- France
- Russia
- Italy
- Switzerland
- Sweden
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- China
- India
- Australia & New Zealand
- Japan
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Apricus Biosciences Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Endo International Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Futura Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Premedon
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Eli Lilly
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Teva Pharmaceutical Industries Limited (Teva)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Zephyr Surgical Implants (ZSI)
- Augusta Medical Systems LLC (Augusta Medical)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Apricus Biosciences Inc.
- Analyst Views
- Section
- Research Methodology
- About Us
- Contact
FAQs
The erectile dysfunction market has been segmented on the basis of therapy type, and region.
The erectile dysfunction market is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, neurogenic disorders, and psychological disorders.
In 2018, North America region dominates the empty capsules market and is expected to continue its dominance over the forecast period owing to well-developed pharmaceuticals sector in the countries of the region.
Key players operating in the erectile dysfunction market includes Teva Pharmaceutical Industries Limited, Bonro Medical, Endo International Plc., Eli Lilly and Company, Futura Medical, Augusta Medical Systems LLC, Pfizer,Cristalia Produtos Quimicos Farmaceuticos Ltda., Premedon,SK Chemicals, Post-T-Vac Medical, Bayer AG, VIVUS Inc., Boston Scientific Corp.,Zephyr Surgical Implants (ZSI), Apricus Biosciences Inc., and Coloplast A/S.